Continuation Breakout Analysis — 2026-11-13

Overview

Market Context: Five continuation breakout signals today is a selective session. Average RVOL is only about 0.8 (0.7, 1.2, 0.6, 1.0, 0.5), so participation is light. The SA Regime is Cautious, with 55.6% of stocks above the SMA-40 and sentiment Very Bearish / Neutral. Only the cleanest setups deserve attention.

Quality Score: 2/5. Signal count is low, volume is below average, and four of five names sit in Medical, which limits diversification. Institutional backing is solid for WST, COR and CSGP, which keeps the score from going lower. Under the Cautious regime, no setup earns a 4+.

Sector Concentration: This is a theme trade. Four of five signals are Medical, and Health Care is the third-strongest sector today (ATR% 1.9%). CSGP (Business Services) is the only outlier. Leadership sectors Utilities and Consumer Staples produced no signals.

Top 5 Picks

SENS ($10.58) — Medical / Medical-Products

Open full analysis on WaveFinder →

Technical Setup: SENS gained 5.4% on RVOL of 1.2, the best volume confirmation on the list. Price sits between zones with no overhead supply identified, so there is open room above. The nearest demand is 4h at 9.86–10.055 (strength 5.9). Caution: ADR is 10.3% and Risk (ATR) is 95.5%, so the stock is volatile and position size should be small. It is 24.3% below its 52-week high.

Entry	Stop	Target
$10.45–$10.60	$9.80	$11.70

Institutional Backing: 107 funds, Bucket B0,B1.

WST ($416.42) — Medical / Medical-Products

Open full analysis on WaveFinder →

Technical Setup: WST is up 1.2% and 5.0% below its 52-week high, with ATR%-M of 3.8 and ADR of only 2.6%. RVOL is a soft 0.6, so volume does not confirm the move. Monthly supply at 442.31–475 (strength 7.6) is 6.22% away, leaving a modest runway. Demand at 361–365.59 is far below (12.21%), so the stop must be tighter than a demand-based one.

Entry	Stop	Target
$413–$418	$398	$440

Institutional Backing: 2,184 funds (INST), Bucket N/A.

COR ($359.03) — Medical / Medical-Distribution

Open full analysis on WaveFinder →

Technical Setup: COR rose 2.8% on RVOL of 1.0 with ATR%-M of 3.9. It is 4.9% below its 52-week high. The risk is that price is at supply: monthly supply at 360.58–374.89 (strength 7.3) is just 0.43% away. A clean close above 374.89 would confirm the continuation. Until then, wait for it.

Entry	Stop	Target
Above $375 (close)	$350	$395

Institutional Backing: 2,891 funds (INST), Bucket N/A, the deepest institutional base today.

RYTM ($115.02) — Medical / Medical - Revenue Biotech

Open full analysis on WaveFinder →

Technical Setup: RYTM gained 4.7% and is 5.9% below its 52-week high, with ATR%-M of 3.9 and ADR of 5.6%. RVOL of 0.7 is weak for a breakout. It is at 4h supply (115.575–116.74, strength 6.4), only 0.48% away. Weekly demand is 15.85% below, so the setup is extended. Wait for a break above supply.

Entry	Stop	Target
Above $117 (close)	$110	$127

Institutional Backing: 559 funds, Bucket B0,B1.

CSGP ($30.96) — Business Services / Comml Svcs-Market Rsrch

Open full analysis on WaveFinder →

Technical Setup: CSGP rose 2.9% but on RVOL of just 0.5, and ATR%-M is only 0.6, which signals little momentum. It is 56.1% below its 52-week high, so this is a recovery rather than a true trend continuation. Weekly supply at 32.84–34.77 (strength 7.2) is 6.07% away. It has the lowest Risk (ATR) at 57.9% but the weakest setup.

Entry	Stop	Target
$30.80–$31.00	$29.50	$32.80

Institutional Backing: 1,429 funds (INST), Bucket N/A.

Honorable Mentions

All five signals are covered in the Top 5 above, so there are no additional tickers to list today.

Strategy Summary

• Overall quality: 2/5. Light volume, a Cautious regime, and no setup with strong RVOL confirmation.
• Key sectors: Medical dominates (RYTM, SENS, WST, COR), with CSGP the lone Business Services name.
• Risk/reward: COR and RYTM are pressed against supply and need a confirmed break before entry. SENS has the most open room but the highest volatility. WST offers a moderate 6% upside to supply.

Stay selective, size positions small, and wait for volume confirmation. Entry, stop and target levels are illustrative and not investment advice.

Signals